$INGN News

Inogen, Inc. (INGN) Q2 2026 Earnings Call Transcript

Inogen, Inc. 2026 Q2 - Results - Earnings Call Presentation

Inogen (NASDAQ:INGN) Falls as Revenue Misses and Full-Year Guidance Trails Estimates

Inogen Lowers FY2026 Sales Guidance from $366.000M-$373.000M to $355.000M-$361.000M vs $369.267M Est

Inogen Sees Q3 Sales $92.400M vs $98.967M Est

Inogen Q2 Sales $95.084M Miss $95.233M Estimate

Inogen Announces the Appointment of Andy Reding as Chief Operating Officer

Inogen Appoints Andy Reding As COO, Effective On July 6, 2026

How The Inogen (INGN) Story Is Shifting With New Targets And Execution Questions

Inogen, Inc. Q1 2026 Earnings Call Summary

Inogen, Inc. (INGN) Q1 2026 Earnings Call Transcript

Inogen Q1 Earnings Call Highlights

Inogen (NASDAQ:INGN) Q1 2026 Earnings: Revenue Beat Masks Guidance Miss, Stock Dips

Inogen (INGN) Reports Q1 Loss, Beats Revenue Estimates

Inogen Announces First Quarter 2026 Financial Results

Inogen, Inc. 2026 Q1 - Results - Earnings Call Presentation

Inogen Affirms FY2026 Sales Guidance of $366.000M-$373.000M vs $369.267M Est

Inogen Sees Q2 Sales $94.000M-$97.000M vs $97.250M Est

Inogen Q1 Adj. EPS $(0.14) Beats $(0.28) Estimate, Sales $85.109M Beat $82.350M Estimate

Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates